These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37306257)

  • 1. Systematic pan-cancer analysis identified neuropilin 1 as an immunological and prognostic biomarker.
    Ma X; Zhao Y; Shi C; Jiang H; Liu H; Wang H; Qin X; Wang Y; Han Z
    Cell Biochem Funct; 2023 Aug; 41(6):658-675. PubMed ID: 37306257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
    Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
    Front Immunol; 2021; 12():646523. PubMed ID: 33679809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy.
    Zhang J; Wang K; Hainisayimu T; Li H
    Oxid Med Cell Longev; 2022; 2022():9614819. PubMed ID: 36046686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic pan-cancer analysis identifies RBM39 as an immunological and prognostic biomarker.
    Zhang R; Wang W; Zhang N; Chen X; Liu W; Zhang L; Liu N
    J Cell Mol Med; 2022 Sep; 26(18):4859-4871. PubMed ID: 35989423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic pan-cancer analysis identifies cuproptosis-related gene DLAT as an immunological and prognostic biomarker.
    Xu L; Wu P; Rong A; Li K; Xiao X; Zhang Y; Wu H
    Aging (Albany NY); 2023 May; 15(10):4269-4287. PubMed ID: 37199628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights Into the Prognostic Value and Immunological Role of NAAA in Pan-Cancer.
    Huang D; Shen J; Zhai L; Chen H; Fei J; Zhu X; Zhou J
    Front Immunol; 2021; 12():812713. PubMed ID: 35069601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Significance and Immunological Role of FBXO5 in Human Cancers: A Systematic Pan-Cancer Analysis.
    Liu P; Wang X; Pan L; Han B; He Z
    Front Immunol; 2022; 13():901784. PubMed ID: 35720327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker.
    Zhang W; Wu C; Zhou K; Cao Y; Zhou W; Zhang X; Deng D
    Front Genet; 2022; 13():993438. PubMed ID: 36685895
    [No Abstract]   [Full Text] [Related]  

  • 9. Systematic pan-cancer analysis insights into ICAM1 as an immunological and prognostic biomarker.
    Yang C; Ni B; Shen L; Li Z; Zhou L; Wu H; Zhang Y; Liu L; Liu J; Tian L; Yan L; Jin X
    FASEB J; 2024 Jul; 38(13):e23802. PubMed ID: 38979944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic pan-cancer analysis identifies
    Chen P; Yang X; Wang P; He H; Chen Y; Yu L; Fang H; Wang F; Huang Z
    Ann Transl Med; 2023 Jan; 11(2):121. PubMed ID: 36819495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANXA2 is a potential biomarker for cancer prognosis and immune infiltration: A systematic pan-cancer analysis.
    Ning Y; Li Y; Wang H
    Front Genet; 2023; 14():1108167. PubMed ID: 36713082
    [No Abstract]   [Full Text] [Related]  

  • 12. A prognostic and immunological analysis of 7B-containing Kelch structural domain (KLHDC7B) in pan-cancer: a potential target for immunotherapy and survival.
    Ding J; Ji X; Liu L; Chen DZ; Luo N; Yu XT; Guo F
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7857-7876. PubMed ID: 37039902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pan-cancer analysis reveals correlation between RAB3B expression and tumor heterogeneity, immune microenvironment, and prognosis in multiple cancers.
    Liu XS; Chen YL; Chen YX; Wu RM; Tan F; Wang YL; Liu ZY; Gao Y; Pei ZJ
    Sci Rep; 2024 Apr; 14(1):9881. PubMed ID: 38688977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Pan-Cancer Analysis of KIF18A as a Marker for Prognosis and Immunity.
    Liu T; Yang K; Chen J; Qi L; Zhou X; Wang P
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value and immunological role of PDCD1 gene in pan-cancer.
    Miao Y; Wang J; Li Q; Quan W; Wang Y; Li C; Wu J; Mi D
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107080. PubMed ID: 33069926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role.
    Zhu H; Hu X; Ye Y; Jian Z; Zhong Y; Gu L; Xiong X
    Front Genet; 2021; 12():687778. PubMed ID: 34594356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of pan-cancer reveals potential of ASF1B as a prognostic and immunological biomarker.
    Hu X; Zhu H; Zhang X; He X; Xu X
    Cancer Med; 2021 Oct; 10(19):6897-6916. PubMed ID: 34472711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic, Immunological, and Mutational Analysis of MTA2 in Pan-Cancer and Drug Screening for Hepatocellular Carcinoma.
    Huang X; Tan J; Chen M; Zheng W; Zou S; Ye X; Li Y; Wu M
    Biomolecules; 2023 May; 13(6):. PubMed ID: 37371463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis.
    Wang G; Li Y; Pan R; Yin X; Jia C; She Y; Huang L; Yang G; Chi H; Tian G
    Aging (Albany NY); 2024 Jan; 16(1):872-910. PubMed ID: 38217545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive pan-cancer analysis reveals the prognostic value and immunological role of SPIB.
    Ding M; Li Q; Tan X; Zhang L; Tan J; Zheng L
    Aging (Albany NY); 2022 Aug; 14(15):6338-6357. PubMed ID: 35969172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.